Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 January 2018 Photo UFS Archive
Young squad did it for Shimlas
The 11th season of this popular rugby competition started on Monday 29 January, with the scoreboard favouring Shimlas on 19 points versus the 17 points of Tuks.

The head coach of the Shimla rugby team is confident that the skills level of the players will stand them in good stead for the upcoming Varsity Cup.

The 11th season of this popular rugby competition started on Monday 29 January, with the scoreboard favouring Shimlas on 19 points versus the 17 points of Tuks. The Shimlas faced last year’s champions, Tuks, in Pretoria. 

The rest of the 2018 Varsity Cup season will have the Shimlas playing on 5 February against Maties (away); 12 February against Wits (home); 19 February against Ikeys (away); 26 February against UJ (home); 12 March against NWU (away); 19 March against Madibaz (home); and 26 March against CUT (home).

Head coach, Hendro Scholtz, believes his players have the ability to play at a high tempo for 80 minutes.

“We don’t have the biggest boys around, so we rely on our speed and ability to throw the ball around. You can focus on your defence as much as you like, but tries will be scored. You simply have to ensure that you outscore your opponents,” said Hendro.

With up to nine players from last year’s squad not available again in 2018, the Shimlas are entering the competition with a very young and inexperienced team. According to Hendro, the big dropout since last year is due to a number of reasons, such as students who finished their studies.

“We will have to battle this Varsity Cup with a very young team, of which 10 players were still U19 last year. We faced the University of Johannesburg in a warm-up match, and for many of them it was an eye-opener. The speed and intensity is at a higher level than they were used to at U19 level,” said Hendro, a former Shimla himself.

He will be assisted by Melusi Mthetwa and Jaco Swanepoel.

* The Shimla squad:
Backs: Sango Xamlashe, Carel-Jan Coetzee, Kurt Eybers, Dian Badenhorst, Frank van Heerden, Francois Agenbach, Arrie Pretorius, Rewan Kruger, Zinedine Booysen, Nakkie Naudé, Lubabalo Dobela, William Eybers, Francois Pretorius, Aya Oliphant, Charl Pretorius, Ruan Henning, Sechaba Matsoele, Athi Halom, Jarik van der Walt, Tiaan Schutte, Marnus Boshoff. Forwards: Johan Kotze (captain), Louis Cloete, Nardus Erasmus, JC Janse van Vuuren, Ruan Roelofse, Magau Mabokela, Jano Botha, Helgard Meyer, Wentzel Vorster, Hanno Snyman, Marco van der Merwe, Merwyn Roos, Raymond Woest, Sibabalo Qoma, Nathan Jordan, Benji Jan van Vuuren, Menzi Nhlabathi, Janco Cloete, Kobus Lombaard, Bertie de Bod, Rholane Ncubuka, Henk Pretorius.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept